Concepedia

Gino Brunori

GB

Statistics

Publications

5

Citations

2.1K

H-Index

5

Active since

2015

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Age UK

Drugs for Neglected Diseases Initiative

London School of Hygiene & Tropical Medicine

GlaxoSmithKline (United States)

Gino Brunori is an author at GlaxoSmithKline (United Kingdom) specializing in life sciences, pharmacology, and cell signaling.

Publications per year

2015–2023

5

Publications

5

Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1

Evanna L. Mills, Dylan G. Ryan, Hiran A. Prag et al. · Nature · 2018 · 1.8K citations

, , +12

mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β <sub>1</sub> –induced collagen biosynthesis

Brintha Selvarajah, Ilan Azuelos, Manuela Platé et al. · Science Signaling · 2019 · 171 citations · Full text

, , +13

DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc <sub>1</sub>

Stéphanie Braillard, Martine Keenan, Jacob Heppell et al. · Science Translational Medicine · 2023 · 28 citations · Full text

, , +13

Short-course combination treatment for experimental chronic Chagas disease

Silvia González, Richard J. Wall, John Thomas et al. · Science Translational Medicine · 2023 · 24 citations · Full text

, , +17

Effects of mid-respiratory chain inhibition on mitochondrial function <i>in vitro</i> and <i>in vivo</i>

Ashley Broom, Jeffrey L. Ambroso, Gino Brunori et al. · Toxicology Research · 2015 · 14 citations · Full text

, , +17

1–5 of 5